Gastrointestinal Tablet Franchise in Ahmedabad

Lesutype 100 Tablet Supplier in Mumbai

Levosulpiride Tablet Distributor in Delhi

Prokinetic Therapy Tablet Manufacturer in Bangalore

Dyspepsia Tablet Stockist in Hyderabad
Gastrointestinal Tablet Exporter in Chandigarh

Home/Products /levosulpiride-100-mg-tablet

Lesutype 100 Tablet

Composition : Levosulpiride (100mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Lesutype 100 Tablet contains Levosulpiride 100mg, a selective dopamine D2 receptor antagonist widely used in gastrointestinal therapy. It improves gastric motility and accelerates gastric emptying, helping relieve symptoms such as bloating, early satiety, and abdominal discomfort.

Levosulpiride works by blocking dopamine receptors in the gastrointestinal tract, which enhances peristaltic activity, increases lower esophageal sphincter tone, and normalizes gastric and intestinal movement. This action supports reduction of nausea, vomiting, and functional dyspepsia symptoms.

Clinically, Lesutype 100 Tablet is indicated for functional dyspepsia, gastroesophageal reflux disease (GERD), diabetic gastroparesis, and nausea associated with various conditions. The tablet formulation ensures accurate dosing, consistent absorption, and ease of administration, supporting long-term therapy.

Regular use under medical supervision helps in improving digestion, reducing gastric discomfort, and enhancing overall gastrointestinal function. Lesutype 100 Tablet remains a trusted prokinetic therapy, offering effective and reliable management of digestive motility disorders.

Read More

About the Product

Lesutype 100 Tablet contains Levosulpiride 100mg, a selective dopamine D2 receptor antagonist widely used in gastrointestinal therapy. It improves gastric motility and accelerates gastric emptying, helping relieve symptoms such as bloating, early satiety, and abdominal discomfort.

Levosulpiride works by blocking dopamine receptors in the gastrointestinal tract, which enhances peristaltic activity, increases lower esophageal sphincter tone, and normalizes gastric and intestinal movement. This action supports reduction of nausea, vomiting, and functional dyspepsia symptoms.

Clinically, Lesutype 100 Tablet is indicated for functional dyspepsia, gastroesophageal reflux disease (GERD), diabetic gastroparesis, and nausea associated with various conditions. The tablet formulation ensures accurate dosing, consistent absorption, and ease of administration, supporting long-term therapy.

Regular use under medical supervision helps in improving digestion, reducing gastric discomfort, and enhancing overall gastrointestinal function. Lesutype 100 Tablet remains a trusted prokinetic therapy, offering effective and reliable management of digestive motility disorders.

Common side effects may include drowsiness, headache, mild dizziness, or gastrointestinal discomfort. Rarely, extrapyramidal symptoms (such as tremors or muscle stiffness), restlessness, or allergic reactions may occur.

Lesutype 50 Tablet is indicated for the management of functional dyspepsia, gastroesophageal reflux disease (GERD), nausea and vomiting, and other gastrointestinal motility disorders, as advised by a physician.

For oral use only. Use strictly under medical supervision. Do not exceed the prescribed dose. Inform your doctor if you have a history of neurological disorders, kidney or liver impairment, or are taking other medications affecting dopamine pathways. Discontinue use and consult a physician if severe reactions occur.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep the tablets tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation